The compounding pharmacies market was valued at US$ 9,442.8 million in 2020 and is projected to reach US$ 14,995.1 million by 2028; it is expected to grow at a CAGR of 5.95% from 2020 to 2028.
Drug shortage crisis across the world, benefits associated with compounded medications, and increasing adoption of customized medicine (Personalized medicine) are among the major factors fueling the market growth. Moreover, growing demand for compounding pharmacy during COVID-19 are expected to foster the market growth during the forecast period. However, product recalls and stringent regulatory requirements hinder the growth of the compounding pharmacies market.
The global compounding pharmacies market is segmented on the basis of product and therapeutic area. Based on product, the market is segmented into oral medications, topical medications, suppositories, and others. The oral medications segment held the largest share of the market in 2020. The growth can be attributed to factors such as it is easy to consume and they come in different forms like solid tablets, capsules, chewable tablets, or lozenges that are easy to be swallowed whole or sucked or as drinkable liquids such as syrups, drops or solutions. Further, the compounding pharmacies market for topical medications segment is expected to grow at the fastest CAGR during 2021–2028. Based on therapeutic area, the compounding pharmacies market is segmented into pain medications, hormone replacement therapies, dermatological applications, and others. The pain medications segment held the largest share of the market in 2020. Moreover, the same segment is estimated to register the highest CAGR in the market during the forecast period.
The World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and the National Health Service (NHS) are among the primary and secondary sources referred to while preparing the report on the compounding pharmacies market.
Drug shortage crisis across the world, benefits associated with compounded medications, and increasing adoption of customized medicine (Personalized medicine) are among the major factors fueling the market growth. Moreover, growing demand for compounding pharmacy during COVID-19 are expected to foster the market growth during the forecast period. However, product recalls and stringent regulatory requirements hinder the growth of the compounding pharmacies market.
The global compounding pharmacies market is segmented on the basis of product and therapeutic area. Based on product, the market is segmented into oral medications, topical medications, suppositories, and others. The oral medications segment held the largest share of the market in 2020. The growth can be attributed to factors such as it is easy to consume and they come in different forms like solid tablets, capsules, chewable tablets, or lozenges that are easy to be swallowed whole or sucked or as drinkable liquids such as syrups, drops or solutions. Further, the compounding pharmacies market for topical medications segment is expected to grow at the fastest CAGR during 2021–2028. Based on therapeutic area, the compounding pharmacies market is segmented into pain medications, hormone replacement therapies, dermatological applications, and others. The pain medications segment held the largest share of the market in 2020. Moreover, the same segment is estimated to register the highest CAGR in the market during the forecast period.
The World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and the National Health Service (NHS) are among the primary and secondary sources referred to while preparing the report on the compounding pharmacies market.
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Global Compounding Pharmacies Market - By Product
1.3.2 Global Compounding Pharmacies Market - By Therapeutic Area
1.3.3 Global Compounding Pharmacies Market- By Geography
2. Compounding Pharmacies Market- Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Compounding Pharmacies Market- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East & Africa PEST Analysis
4.2.5 South and Central America PEST Analysis
4.3 Expert Opinion
5. Compounding Pharmacies Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Drug Shortage Crisis Across the World
5.1.2 Benefits of Compounded Medications
5.1.3 Increasing Adoption of Customized Medicine (Personalized Medicine)
5.2 Market Restraints
5.2.1 Product Recalls and Stringent Regulatory Requirements
5.3 Market Opportunities
5.3.1 Growing Demand for Compounding Pharmacy During COVID-19
5.4 Future Trends
5.4.1 Growing Outsourcing Facilities for Manufacturing and Sales of Products
5.5 Impact Analysis
6. Compounding Pharmacies Market- Global Analysis
6.1 Global Compounding Pharmacies Market Revenue Forecast and Analysis
6.2 Global Compounding Pharmacies Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Compounding Pharmacies Market Analysis - By Product
7.1 Overview
7.2 Compounding Pharmacies Market Revenue Share, by Product (2020 and 2028)
7.3 Oral Medications
7.3.1 Overview
7.3.2 Oral Medications: Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Topical Medications
7.4.1 Overview
7.4.2 Topical Medications: Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Suppositories
7.5.1 Overview
7.5.2 Suppositories: Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
8. Compounding Pharmacies Market - By Therapeutic Area
8.1 Overview
8.2 Compounding Pharmacies Market, by Therapeutic Area, 2020 and 2028 (%)
8.3 Pain Medications
8.3.1 Overview
8.3.2 Pain Medications: Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Hormone Replacement Therapies
8.4.1 Overview
8.4.2 Hormone Replacement Therapies: Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Dermatological Applications
8.5.1 Overview
8.5.2 Dermatological Applications: Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
9. Compounding Pharmacies Market Revenue and Forecasts to 2028 - Geographical Analysis
9.1 North America Compounding Pharmacies Market Revenue and Forecasts to 2028
9.1.1 North America Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.1.1.1 North America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
9.1.1.2 North America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
9.1.2 North America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)
9.1.3 US Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.1.4 US Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.1.4.1 US Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
9.1.4.2 US Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
9.1.5 Canada Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.1.5.1 Canada Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.1.5.2 Canada Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
9.1.5.3 Canada Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
9.1.6 Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.1.6.1 Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.1.6.2 Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
9.1.6.3 Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
9.2 Europe Compounding Pharmacies Market Revenue and Forecasts to 2028
9.2.1 Europe Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.2.1.1 Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
9.2.1.2 Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
9.2.2 Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)
9.2.3 UK Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.2.3.1 UK Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.2.3.2 UK Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
9.2.3.3 UK Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
9.2.4 Germany Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.2.4.1.1 Germany Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.2.4.2 Germany Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
9.2.4.3 Germany Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
9.2.4.4 France Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.2.5 France Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.2.5.1 France Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
9.2.5.2 France Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
9.2.6 Italy Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.2.6.1 Italy Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.2.6.2 Italy Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
9.2.6.3 Italy Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
9.2.7 Spain Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.2.8 Spain Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.2.8.1 Spain Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
9.2.8.2 Spain Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
9.2.9 Rest of Europe Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.2.10 Rest of Europe Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.2.10.1 Rest of Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
9.2.10.2 Rest of Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
9.3 Asia Pacific: Compounding Pharmacies Market
9.3.1 Overview
9.3.2 Asia Pacific: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
9.3.3 Asia Pacific: Compounding Pharmacies Market, by Product, 2019-2028 (USD Million)
9.3.4 Asia Pacific: Compounding Pharmacies Market, by Therapeutic Area - 2019-2028 (USD Million)
9.3.5 Asia Pacific: Compounding Pharmacies Market, by Country, 2020 & 2028 (%)
9.3.6 China: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
9.3.6.1 China: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
9.3.6.2 China: Compounding Pharmacies Market, by Product, 2019-2028 (USD Million)
9.3.6.3 China: Compounding Pharmacies Market, by Therapeutic Area, 2019-2028 (USD Million)
9.3.7 Japan: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
9.3.7.1 Japan: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
9.3.7.2 Japan: Compounding Pharmacies Market, by Product, 2019-2028 (USD Million)
9.3.7.3 Japan: Compounding Pharmacies Market, by Therapeutic Area, 2019-2028 (USD Million)
9.3.8 India: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
9.3.8.1 India: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
9.3.8.2 India: Compounding Pharmacies Market, by Product, 2019-2028 (USD Million)
9.3.8.3 India: Compounding Pharmacies Market, by Therapeutic Area, 2019-2028 (USD Million)
9.3.9 South Korea: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
9.3.9.1 South Korea: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
9.3.9.2 South Korea: Compounding Pharmacies Market, by Product, 2019-2028 (USD Million)
9.3.9.3 South Korea: Compounding Pharmacies Market, by Therapeutic Area, 2019-2028 (USD Million)
9.3.10 Australia: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
9.3.10.1 Australia: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
9.3.10.2 Australia: Compounding Pharmacies Market, by Product, 2019-2028 (USD Million)
9.3.10.3 Australia: Compounding Pharmacies Market, by Therapeutic Area, 2019-2028 (USD Million)
9.3.11 Rest of Asia-Pacific: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
9.3.11.1 Rest of Asia-Pacific: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
9.3.11.2 Rest of Asia-Pacific: Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (USD Million)
9.3.11.3 Rest of Asia-Pacific: Compounding Pharmacies Market, by Therapeutic Area - Revenue and Forecast to 2028 (USD Million)
9.4 East & Africa: Compounding Pharmacies Market
9.4.1 Overview
9.4.2 Middle East and Africa: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
9.4.3 Middle East and Africa: Compounding Pharmacies Market, by Product, 2019-2028 (USD Millions)
9.4.4 Middle East and Africa: Compounding Pharmacies Market, by Therapeutic Area, 2019-2028 (USD Million)
9.4.5 Middle East and Africa: Compounding Pharmacies Market, by Country, 2020& 2028 (%)
9.4.6 UAE: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
9.4.6.1 UAE: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
9.4.6.2 UAE: Compounding Pharmacies Market, by Product, 2019-2028 (USD Millions)
9.4.6.3 UAE: Compounding Pharmacies Market, by Therapeutic Area, 2019-2028 (USD Million)
9.4.7 Saudi Arabia: Compounding Pharmacies Market - Revenue and Forecast to 2027 (USD Million)
9.4.7.1 Saudi Arabia: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
9.4.7.2 Saudi Arabia: Compounding Pharmacies Market, by Product, 2019-2028 (USD Millions)
9.4.7.3 Saudi Arabia: Compounding Pharmacies Market, by Therapeutic Area, 2019-2028 (USD Million)
9.4.8 South Africa: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
9.4.8.1 South Africa: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
9.4.8.2 South Africa: Compounding Pharmacies Market, by Product, 2019-2028 (USD Millions)
9.4.8.3 South Africa: Compounding Pharmacies Market, by Therapeutic Area, 2019-2028 (USD Million)
9.4.9 Rest of Middle East and Africa: Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
9.4.9.1 Rest of Middle East and Africa: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
9.4.9.2 Rest of Middle East and Africa Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (USD Million)
9.4.9.2.1 Rest of Middle East and Africa: Compounding Pharmacies Market, by Therapeutic Area, 2019-2028 (USD Million)
9.5 South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028
9.5.1 South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.5.1.1 South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
9.5.1.2 South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
9.5.2 South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)
9.5.3 Argentina Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.5.4 Argentina Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.5.4.1 Argentina Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
9.5.4.2 Argentina Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
9.5.5 Brazil Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.5.6 Brazil Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.5.6.1 Brazil Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
9.5.6.2 Brazil Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
9.5.7 Rest of South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.5.8 Rest of South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.5.8.1 Rest of South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
9.5.8.2 Rest of South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
10. Impact Of COVID-19 Pandemic on Global Compounding Pharmacies Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Rest of The World: Impact Assessment of COVID-19 Pandemic
11. Compounding Pharmacies Market- Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 Fagron, Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Triangle Compounding Pharmacy
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 B.Braun Melsungen AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 PharMEDium Healthcare Holdings, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Fresenius Kabi AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Avella specialty pharmacy
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Vertisis Custom Pharmacy
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 US Compounding Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Belle Santé Diagnostic & Therapeutic Institute Pvt. Ltd.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Elixir Compounding Pharmacy
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About the Publisher
13.2 Glossary of Terms
List of Tables
Table 1. A few drugs that are in short supply are listed below:
Table 2. North America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 3. North America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
Table 4. US Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 5. US Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
Table 6. Canada Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 7. Canada Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
Table 8. Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 9. Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
Table 10. Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 11. Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
Table 12. UK Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 13. UK Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
Table 14. Germany Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 15. Germany Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
Table 16. France Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 17. France Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
Table 18. Italy Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 19. Italy Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
Table 20. Spain Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 21. Spain Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
Table 22. Rest of Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 23. Rest of Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
Table 24. Asia Pacific Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (USD Million)
Table 25. Asia Pacific Compounding Pharmacies Market, by Therapeutic Area - Revenue and Forecast to 2028 (USD Million)
Table 26. China Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (USD Million)
Table 27. China Compounding Pharmacies Market, by Therapeutic Area - Revenue and Forecast to 2028 (USD Million)
Table 28. Japan Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (USD Million)
Table 29. Japan Compounding Pharmacies Market, by Therapeutic Area - Revenue and Forecast to 2028 (USD Million)
Table 30. India Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (USD Million)
Table 31. India Compounding Pharmacies Market, by Therapeutic Area - Revenue and Forecast to 2028 (USD Million)
Table 32. South Korea Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (USD Million)
Table 33. South Korea Compounding Pharmacies Market, by Therapeutic Area - Revenue and Forecast to 2028 (USD Million)
Table 34. Australia Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (USD Million)
Table 35. Australia Compounding Pharmacies Market, by Therapeutic Area - Revenue and Forecast to 2028 (USD Million)
Table 36. Rest of Asia-Pacific: Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (USD Million)
Table 37. Rest of Asia-Pacific: Compounding Pharmacies Market, by Therapeutic Area - Revenue and Forecast to 2028 (USD Million)
Table 38. Middle East and Africa Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (USD Millions)
Table 39. Middle East and Africa Compounding Pharmacies Market, by Therapeutic Area - Revenue and Forecast to 2028 (USD Million)
Table 40. UAE Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (USD Millions)
Table 41. UAE Compounding Pharmacies Market, by Therapeutic Area - Revenue and Forecast to 2028 (USD Million)
Table 42. Saudi Arabia Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (USD Millions)
Table 43. Saudi Arabia Compounding Pharmacies Market, by Therapeutic Area - Revenue and Forecast to 2028 (USD Million)
Table 44. South Africa Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (USD Millions)
Table 45. South Africa Compounding Pharmacies Market, by Therapeutic Area - Revenue and Forecast to 2028 (USD Million)
Table 46. Rest of Middle East and Africa Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (USD Million)
Table 47. Rest of Middle East and Africa Compounding Pharmacies Market, by Therapeutic Area - Revenue and Forecast to 2028 (USD Million)
Table 48. South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 49. South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
Table 50. Argentina Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 51. Argentina Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
Table 52. Brazil Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 53. Brazil Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
Table 54. Rest of South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 55. Rest of South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
Table 56. Organic Developments Done By Companies
Table 57. Inorganic Developments Done By Companies
Table 58. Glossary of Terms, Compounding Pharmacies MarketList of Figures
Figure 1. Compounding Pharmacies Market Segmentation
Figure 2. Compounding Pharmacies Segmentation, By Region
Figure 3. Global Compounding Pharmacies Market Overview
Figure 4. Oral Medications Held Largest Share of Product Segment in Compounding Pharmacies Market
Figure 5. North America to Show Remarkable Growth During Forecast Period
Figure 6. Compounding Pharmacies Market, by Geography (US$ Million)
Figure 7. Global Compounding Pharmacies Market- Leading Country Markets (US$ Million)
Figure 8. Global Compounding Pharmacies Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East & Africa: PEST Analysis
Figure 13. South and Central America: PEST Analysis
Figure 14. Compounding Pharmacies Market Impact Analysis of Drivers and Restraints
Figure 15. Global Compounding Pharmacies Market- Revenue Forecast and Analysis - 2020- 2028
Figure 16. Global Compounding Pharmacies Market- By Geography Forecast and Analysis - 2020- 2028
Figure 17. Market Positioning of Key Players in Global Compounding Pharmacies Market
Figure 18. Compounding Pharmacies Market Revenue Share, by Product (2020 and 2028)
Figure 19. Oral Medications: Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Topical Medications: Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Suppositories: Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. Compounding Pharmacies Market, by Therapeutic Area, 2020 and 2028 (%)
Figure 24. Pain Medications: Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Hormone Replacement Therapies: Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Dermatological Applications: Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. Others: Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. North America Compounding Pharmacies Market Revenue Overview, By Country, 2020 (US$ Mn)
Figure 29. North America Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 30. North America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)
Figure 31. US Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 32. Canada Compounding Pharmacies Market Revenue And Forecasts to 2028 (US$ Mn)
Figure 33. Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 34. Europe Compounding Pharmacies Market Revenue Overview, By Country, 2020 (US$ Mn)
Figure 35. Europe Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 36. Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)
Figure 37. UK Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 38. Germany Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 39. France Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 40. Italy Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 41. Spain Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 42. Rest of Europe Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 43. Asia Pacific: Compounding Pharmacies Market, by Key Country - Revenue (2020) (USD Million)
Figure 44. Asia Pacific Compounding Pharmacies Market Revenue and Forecast to 2028 (USD Million)
Figure 45. China: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
Figure 46. Japan: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
Figure 47. India: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
Figure 48. South Korea: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
Figure 49. Australia: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
Figure 50. Rest of Asia-Pacific: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
Figure 51. Middle East & Africa: Compounding Pharmacies Market, by Key Country - Revenue (2020) (USD Million)
Figure 52. Middle East and Africa Compounding Pharmacies Market Revenue and Forecast to 2028 (USD Millions)
Figure 53. UAE: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
Figure 54. Saudi Arabia: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
Figure 55. South Africa: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
Figure 56. Rest of Middle East and Africa: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
Figure 57. South and Central America Compounding Pharmacies Market Revenue Overview, By Country, 2020 (US$ Mn)
Figure 58. South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 59. South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)
Figure 60. Argentina Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 61. Brazil Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 62. Rest of South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 63. Impact of COVID-19 Pandemic in North American Country Markets
Figure 64. Impact of COVID-19 Pandemic in European Country Markets
Figure 65. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 66. Impact Of COVID-19 Pandemic in Rest of The World Market
Figure 67. Growth Strategies Done by the Companies in the Market, (%)
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Fagron, Inc.
- Elixir Compounding Pharmacy
- Avella specialty pharmacy
- B. Braun Melsungen AG
- PharMEDium Healthcare Holdings, Inc.
- Fresenius Kabi AG
- Belle Santé Diagnostic & Therapeutic Institute Pvt. Ltd
- Triangle Compounding Pharmacy
- Vertisis Custom Pharmacy
- US Compounding Inc.
Table Information
| Report Attribute | Details |
|---|---|
| Published | March 2021 |
| Forecast Period | 2020 - 2028 |
| Estimated Market Value ( USD | $ 9442.8 Million |
| Forecasted Market Value ( USD | $ 14995.1 Million |
| Compound Annual Growth Rate | 5.9% |
| Regions Covered | Global |
